Final progression-free survival results from the J-ALEX study of alectinib versus crizotinib in ALK-positive non-small-cell lung cancer

Nakagawa, K; Hida, T; Nokihara, H; Morise, M; Azuma, K; Kim, YH; Seto, T; Takiguchi, Y; Nishio, M; Yoshioka, H; Kumagai, T; Hotta, K; Watanabe, S; Goto, K; Satouchi, M; Kozuki, T; Koyama, R; Mitsudomi, T; Yamamoto, N; Asakawa, T; Hayashi, M; Hasegawa, W; Tamura, T

Nakagawa, K (corresponding author), Kindai Univ, Fac Med, Dept Med Oncol, 377-2 Ohnohigashi, Osaka, Osaka 5898511, Japan.

LUNG CANCER, 2020; 139 (): 195

Abstract

Objectives: The J-ALEX study compared the efficacy and safety of alectinib with crizotinib in Japanese patients with advanced ALK-positive non-small-c......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索